Results 161 to 170 of about 95,708 (262)

Medicines, misinformation and machines: Navigating infodemics in the generative AI era

British Journal of Clinical Pharmacology, EarlyView.
Health information is now widely accessed through smartphones, online searches and increasingly through generative artificial intelligence (AI). These systems create new opportunities for communication, and in some routine contexts, well‐governed AI assistants could reduce exposure to lower quality sources by providing cautious, evidence‐aligned ...
Natansh D. Modi, Lisa M. Kalisch Ellett, Michael D. Wiese, Ashley M. Hopkins   +3 more
wiley   +1 more source

Spontaneous lymphoproliferation differentiates two groups of HTLV-1 asymptomatic carriers: with and without high cell proliferation and death. [PDF]

Immunol Res
de Souza Porto M, Mitiko T, Folgosi V, Vasconcelos D, Domingues M, Haziot M, Smid J, Marcusso R, Nukui Y, Oliveira ACP, Assone T, Casseb J, Benard G.   +12 more
europepmc   +1 more source

Unsupervised machine learning for multi‐system adverse event pattern detection in pharmacovigilance: A proof‐of‐concept analysis of fluoroquinolone reports in FAERS

British Journal of Clinical Pharmacology, EarlyView.
. Aims Traditional pharmacovigilance detects single drug–event associations but cannot readily characterize multi‐system adverse‐event patterns such as fluoroquinolone‐associated disability. We evaluated unsupervised machine learning for this purpose, using fluoroquinolones as an exemplar.
Niaz Chalabianloo, Sheikh S. Abdullah, Kamran Sedig, Flory T. Muanda   +3 more
wiley   +1 more source

Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence. [PDF]

CNS Drugs
McIntyre RS, Kato M, Thase ME, Therrien F, Marrache AM, Ikehara K, Ardic F, Boucher M.   +7 more
europepmc   +1 more source

Current Approaches in the Management of Complicated Macular Holes. [PDF]

Turk J Ophthalmol
Avcı R, Mavi Yıldız A, Nawrocka ZA, Rizzo S, Yılmaz S, Avcı E, Giannuzzi F, Loya A, Mahmoud TH.   +8 more
europepmc   +1 more source

pyFDRT: An open‐source Python tool for Fourier‐transform analysis of the distribution of relaxation times in electrochemical impedance spectra

Bulletin of the Korean Chemical Society, EarlyView.
pyFDRT is an open‐source tool that converts an impedance spectrum into a quantitative equivalent circuit. Its Fourier‐transform stage requires no discretization basis or regularization parameter, and the non‐negative refinement selects its own parameters, and an information criterion determines the relaxation process count.
Chung‐Yul Yoo, Jaeku Park, Jeongjin Kim   +2 more
wiley   +1 more source

Longitudinal patient-reported outcomes and predictors of improvement in chemotherapy-induced peripheral neuropathy a secondary analysis of a randomized trial. [PDF]

Front Pharmacol
Salah H, Shaaban AH, Abdelrahman MA, Osama H, El-Kalaawy AM.   +4 more
europepmc   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

British Journal of Clinical Pharmacology, EarlyView.
Christina Gao, Ashley M. Hopkins, Andrew Rowland, Stephen Bacchi   +3 more
wiley   +1 more source

Hot and cold deserts as eco‐evolutionary arenas for understanding plant resistance to multiple abiotic stressors

Biological Reviews, EarlyView.
ABSTRACT During their long evolutionary history, land plants have evolved a range of adaptations to different abiotic stressors. These help explain present‐day diversity and distribution patterns, as well as the potential resilience of natural and agricultural systems to a changing climate. Most previous research has focused on adaptation to individual
Marc Fradera‐Soler, Natasha Barbolini, Anže Žerdoner Čalasan, Marian Schubert, Catarina Rydin, Olwen M. Grace, Aelys M. Humphreys   +6 more
wiley   +1 more source

The Moral Manager in the Market: How CFOs' Ethical Intelligence Drives ESG Investment in Emerging Economies' Dual Markets

Business Strategy and the Environment, EarlyView.
ABSTRACT What propels a CFO in an emerging economy to champion ESG investments when formal regulations are weak? Moving beyond structural explanations, we provide a behavioural account arguing that a manager's internal ethical compass—moral intelligence (MI)—is a key driver.
AmirHossein ArminKia, Davood Askarany, Seyed Hamed Fahimifard, Seyedeh Kimia Shafahi Moghadam, Seyed Shayan Alavi   +4 more
wiley   +1 more source